Cannabinoid Receptors



11 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A12849 SALE

AB-FUBINACA

-
AB-FUBINACA was first synthesized by Pfizer as a potent CB1 receptor modulator for potential therapeutic use, but recently was identified along with AB-PINACA (Item No. 14038) in illegal herbal products.
A12914 SALE

AM251

CB1 receptor antagonist
AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors.
A14993 SALE

AM630

CB2 antagonist
AM630 is a selectivity CB2 antagonist with Ki of 31.2 nM, > 150 fold selectivity over CB1 receptor.
A11938

BML-190

CB2 receptor ligand
BML-190 is a selective inverse agonist of the human cannabinoid CB2 receptor.
A11942

CP 945598 HCl

CB1 antagonist
CP 945598 is a potent and highly selective CB1 antagonist.
A11253

GW842166X

CB2 receptor agonist
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
A11780 SALE

JWH 133

CB2 agonist
JWH-133 is a potent selective CB2 receptor agonist, with a Ki of 3.4nM and selectivity of around 200x for CB2 over CB1 receptors.
A11939

MDA 19

CB2 agonist
MDA 19 is a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor.
A11513

Org 27569

CB1 modulator‎
Org 27569 is a potent CB1 receptor allosteric modulator (pEC50 = 8.24).
A11547 SALE

Rimonabant (SR141716)

-
Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
A11932 SALE

WIN 55,212-2 mesylate

CB receptor agonist
WIN 55,212-2 is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling.

11 Item(s)

per page

Set Descending Direction